Helicobacter pylori

Associated infections

• Chronic active gastritis
• Gastric and duodenal ulcer disease
• Gastric adenocarcinoma
• Gastric MALT lymphoma
• Functional dyspepsia associated with infection
• Iron deficiency anaemia unresponsive to supplementation in a subset of patients
• Immune thrombocytopenic purpura in a subset of patients

Transmission route

Natural transmission of H. pylori is person to person, predominantly oral-oral or faecal-oral, and occurs typically within households and during childhood. Intrafamilial clustering is well described, with maternal transmission a recognised pattern, and prevalence correlates strongly with crowding, socioeconomic conditions and sanitation during early life. Acquisition in adulthood is comparatively uncommon in populations with good sanitation, which is one reason why iatrogenic acquisition in adults is epidemiologically conspicuous when it occurs.

The role of water in natural transmission is contested and, importantly for reprocessing purposes, distinct from the question of whether H. pylori colonises treated water systems. Molecular detection of H. pylori DNA has been reported from environmental water in some settings with high community prevalence, and faecal-oral spread via contaminated water has been proposed as a route in those settings. This is not the same as the organism growing in a treated hospital water distribution system, and there is no basis for treating H. pylori as a water-system coloniser or as an indicator of water treatment performance in an Australian healthcare reprocessing context.

The transmission route of practical relevance to endoscopy services is instrument-borne. Studies of gastroscopy have shown that endoscopes and biopsy forceps are frequently contaminated after procedures performed on infected patients, which is unsurprising given that the organism resides on the mucosal surface being instrumented and in the gastric mucus that coats the instrument. Iatrogenic transmission between patients via inadequately reprocessed instruments has been demonstrated, and reported transmission rates in the era of poor reprocessing practice were of the order of a few cases per thousand procedures in settings where background prevalence was high. Those figures are historical and reflect practice that predates modern validated reprocessing, but they establish the mechanism.

Biopsy forceps and other reusable accessories deserve specific mention because they contact mucosa directly, are mechanically complex, and have historically been a weak point in reprocessing. Accessories that penetrate mucosa are critical devices requiring sterilisation, and single-use accessories remove this pathway entirely. Where reusable accessories remain in service, their cleaning and reprocessing is as much part of H. pylori control as the endoscope itself.

Relevance in endoscopy and reprocessing

H. pylori is the clearest example in this group of an organism whose endoscopy relevance is real, documented and entirely about the instrument rather than the water. Gastroscopy instruments a mucosal surface on which the organism lives, at a prevalence that in many populations means a substantial proportion of procedures involve an infected patient. Post-procedure contamination of endoscopes and biopsy forceps following gastroscopy on infected patients is well documented, and patient-to-patient transmission attributable to inadequately reprocessed gastroscopes has been demonstrated. This places H. pylori among the small number of organisms for which endoscope-mediated transmission is an established fact rather than a theoretical concern, alongside the enteric Gram-negatives and the duodenoscope-associated multidrug-resistant organisms.

Critically, H. pylori is not a disinfectant-tolerant organism, and its endoscopic transmission history should not be read as a disinfection problem. Studies of conventional reprocessing, including manual cleaning followed by glutaraldehyde immersion and reprocessing by automated systems, have shown reliable elimination of the organism from contaminated gastroscopes. The organism has no spore form, no mycobacterial cell wall, no biofilm mode of life in the reprocessing environment, and no documented reduced susceptibility to the high-level disinfectants in ordinary use. Every reported transmission is therefore attributable to a process failure rather than to intrinsic resistance: omitted or abbreviated manual cleaning, failure to brush or flush the biopsy and suction channels, damaged or obstructed channels, reuse of inadequately reprocessed or inadequately sterilised biopsy forceps, shortened disinfectant contact time, exhausted or under-strength disinfectant, or bypassing of the process altogether between rapidly sequenced cases.

Because H. pylori is fragile outside the host, it also carries less storage-related risk than water organisms. It does not multiply in a damp channel during storage in the way P. putida does, and a device that has been correctly cleaned and disinfected will not accumulate H. pylori over a storage interval. The window of risk is short and concentrated: it opens at the end of the procedure and closes when the device completes a validated cycle. That has practical consequences for turnaround pressure, since the highest-risk scenario for this organism is a busy gastroscopy list in which pre-cleaning is deferred, drying of bioburden in the channels occurs, and cleaning time is compressed to keep the room moving. Bedside pre-cleaning immediately after withdrawal, adherence to the full manual cleaning protocol, correct handling of biopsy channels and accessories, and resistance to schedule-driven shortcuts are the controls that actually govern this organism. Detection of H. pylori is not part of routine reprocessing surveillance and no guidance requires testing for it; assurance is provided by process compliance and validation rather than by sampling.

Interpreting a detection

H. pylori is not a recognised final rinse water contaminant, is not an indicator organism for water quality monitoring, and does not feature in the surveillance schedules set out in reprocessing guidance. Routine water or endoscope surveillance culture methods are not designed to recover it, since it requires microaerophilic incubation on enriched media over several days and would be outgrown or simply missed by standard aerobic culture. For practical purposes, a detection of H. pylori in a routine water or final rinse surveillance sample should not be expected to occur at all.

If such a result is nevertheless reported, the first question is methodological rather than operational. Establish what method produced the result. A molecular or PCR-based detection reports nucleic acid and does not establish the presence of viable, culturable, transmissible organisms, and detection of H. pylori DNA in water has been reported without corresponding recovery of culturable organisms. A culture-based report should prompt confirmation of the identification, since spiral and curved Gram-negative organisms including Campylobacter, Arcobacter and various environmental curved rods can be confused with Helicobacter on morphology alone, and automated identification systems can misassign unusual isolates. Confirm what media and atmosphere were used, whether appropriate controls were run, and whether any gastric biopsy or clinical Helicobacter specimens were processed in the same batch, since laboratory cross-contamination is a plausible explanation for an otherwise implausible finding.

Once methodology has been addressed, the interpretive framing is that a genuine H. pylori detection in a reprocessing sample points to patient-derived gastric material rather than to water-system colonisation, and the investigation follows the same logic as for any other patient-derived organism: manual cleaning adequacy, channel and accessory reprocessing, device integrity, and the aseptic technique used to collect the sample. Remediation of the water treatment train would be an irrelevant response. Because a single isolate of an organism this fastidious is more likely to represent a methodological problem than a real event, the response to a first detection is confirmation and review rather than immediate escalation; but a confirmed, culture-based, correctly identified isolate from a reprocessed gastroscope would be a significant finding warranting quarantine of the device and notification of infection prevention. The broader point for a reprocessing unit is that assurance against H. pylori transmission is not obtained through water surveillance at all. It is obtained through documented compliance with cleaning and high-level disinfection, validated cycle parameters, correct handling of biopsy accessories, and periodic audit of practice under real workload conditions.

Antimicrobial resistance

Antimicrobial resistance in H. pylori is a therapeutic problem rather than a disinfection or reprocessing one, and the distinction should be maintained clearly when the organism is discussed in an infection prevention context. Clarithromycin resistance, mediated principally by point mutations in the peptidyltransferase region of the 23S rRNA gene, has risen internationally and is the single most important driver of eradication failure; in many regions prevalence has passed the threshold above which empirical clarithromycin-based triple therapy is no longer recommended. Resistance to metronidazole, mediated largely by mutations in the rdxA and frxA nitroreductase genes, is widespread and in some populations exceeds half of isolates, although its effect on outcome can be partly overcome by dose and duration. Fluoroquinolone resistance through gyrA mutation is increasing and is regionally variable, while resistance to amoxicillin, tetracycline and rifabutin remains comparatively uncommon.

The World Health Organization has listed clarithromycin-resistant H. pylori among its priority pathogens for antibiotic research and development, and current management guidance increasingly favours susceptibility-guided therapy or regimens selected against local resistance data rather than uniform empirical treatment. Molecular resistance testing on gastric biopsy material, where available, allows tailoring without culture.

None of this alters reprocessing requirements in any respect. Resistance mechanisms in H. pylori operate against specific antibiotic targets and confer no cross-tolerance to aldehyde, peracid or other high-level chemical disinfectants, nor to thermal disinfection or sterilisation. A clarithromycin-resistant or multidrug-resistant strain is inactivated by a validated reprocessing cycle exactly as a fully susceptible strain is. The organism has no spore form and no environmentally hardy stage of relevance to reprocessing. Correct cleaning and validated high-level disinfection therefore remain fully effective, and the reprocessing response to a resistant strain in a patient population is the same as for any other patient: complete, uncompromised execution of the standard process.